Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity

Cisplatin is a widely used drug in the treatment of various solid tumors, such as ovarian cancer. However, while the acquired resistance significantly limits the success of therapy, some tumors, such as colorectal cancer, are intrinsically insensitive to cisplatin. Only a small amount of intracellul...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sophie Möltgen, Eleonora Piumatti, Giuseppe M. Massafra, Sabine Metzger, Ulrich Jaehde, Ganna V. Kalayda
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-05-01
Col·lecció:	Cells
Matèries:	cisplatin resistance BODIPY-cisplatin oxaliplatin vimentin glutathione-S-transferase π growth factor receptor-bound protein 2
Accés en línia:	https://www.mdpi.com/2073-4409/9/6/1322
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!